Physician profile
Nikesh Patel
NPI 1346771888
$14,219.92
in general payments reported to CMS, 2019-2025
10 companies · $305 in 2025
The $305 reported for 2025 was more than what a typical Physical Medicine & Rehabilitation provider received nationally (typical 2025 total: $138).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $2,637 · 2022: $9,723 · 2023: $1,091 · 2024: $465 · 2025: $305.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,549 · Travel and Lodging: $311.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,548.69 |
| Travel and Lodging | $311.21 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $9,579.09 | 2021-2024 | Wavewriter Alpha Prime 16 |
| Nevro Corp. | $1,758.98 | 2021-2022 | |
| Medtronic, INC. | $1,722.65 | 2021-2025 | Intellis Adaptivestim |
| Merz Pharmaceuticals, LLC | $323.87 | 2021-2022 | |
| Painteq LLC | $302.50 | 2022-2023 | Painteq |
| Ipsen Biopharmaceuticals, INC | $264.28 | 2022 | |
| Spr Therapeutics, INC | $123.30 | 2021-2025 | Sprint Pns System |
| Stryker Corporation | $102.34 | 2023-2025 | Mild Device Kit, Spinejack |
| Avanos Medical | $28.20 | 2022 | |
| Abbvie INC. | $14.71 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nikesh Patel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.